Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Snynf crawled time : 01:00 save search
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published: 2024-03-13 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
report research global
Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences
Published: 2024-03-05 (Crawled : 01:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.32%
H: 0.22%
C: -0.2%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
report sciences global key market
Global Glucagon-Like Peptide 1 (GLP-1) Agonist Market Analysis Report 2024: A $133.5 Billion in 2030 Featuring Eli Lilly and Co, Pfizer, Sanofi, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk
Published: 2024-02-27 (Crawled : 01:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -1.72%
H: 2.54%
C: 2.54%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -2.2%
H: 2.39%
C: 1.34%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.01%
H: 0.79%
C: 0.6%
report agonist global market
North America and Europe Bus ADAS Market Analysis and Growth Opportunities, 2022-2024 and Forecasts to 2030: Coach Buses to Incorporate Significant ADAS Features while Transit Buses Move Toward Autonomy
Published: 2024-02-27 (Crawled : 01:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
america europe bus growth coach market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.26%
H: 1.36%
C: 1.36%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -0.85%
H: 1.12%
C: 0.43%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
UCBJY | $64.07 -4.38% 72K
|
Manufacturing
|
| O: 1.46%
H: 0.44%
C: 0.44%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -0.27%
H: 0.0%
C: -1.17%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.2%
H: 0.14%
C: -0.48%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.06%
H: 0.46%
C: 0.29%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.69%
H: 1.42%
C: 1.22%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 2.37%
H: 1.51%
C: 0.79%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.65%
H: 1.63%
C: 1.48%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.88%
H: 1.46%
C: 1.13%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -2.81%
H: 2.08%
C: 1.38%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.35%
H: 1.15%
C: 0.96%
lung reach cancer cell diagnostics therapy market
Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA
Published: 2024-02-20 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: -0.8%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.53%
H: 0.0%
C: 0.0%
ibi311 disease thyroid eye trial
Global Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report 2023-2030
Published: 2024-02-13 (Crawled : 01:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
report global trends therapeutics market
Global Biopharmaceutical Fermentation Market Analysis Report 2023-2028: Expanding Biosimilars Market, Continuous Fermentation Processes, and Growing Pipeline of Biopharmaceuticals Bolster Growth
Published: 2023-12-15 (Crawled : 01:00) - prnewswire.com
LZAGF | $579.0 -19.1% 49
|
Health Technology
|
| O: 4.1%
H: 0.31%
C: -1.9%
LZAGY | $57.3 0.02% 33K
|
Professional, Scientific, and T...
|
| O: 3.28%
H: 0.46%
C: -0.61%
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
DHR | $236.36 -1.27% 0.0% 4.2M
|
Health Technology
|
| O: 0.24%
H: 0.05%
C: -1.11%
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: -1.8%
H: 1.46%
C: 1.19%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
report pipeline global growing growth market
Latest Odronextamab Data in Relapsed/Refractory Follicular Lymphoma Showed Compelling Responses and Overall Maintenance of Patient-Reported Outcomes
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: -0.2%
H: 1.35%
C: 1.19%
Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
sarclisa disease plus
Global Bioreactors Market Forecast Report 2023-2033: Influence of Single-use Technologies on Market Direction
Published: 2023-12-08 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
DHR | $236.36 -1.27% 0.0% 4.2M
|
Health Technology
|
| O: 0.04%
H: 0.46%
C: -0.69%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
report global market
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study
Published: 2023-12-07 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.66%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
positive ongoing collaboration study
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: -0.2%
H: 1.7%
C: 1.3%
rient-16 treatment results study
Drugs For Benign Prostatic Hypertrophy Market Report 2024 - Market to Reach $5.45 billion in 2028 - Opportunities in Minimally Invasive Treatments, Personalized Medicine and Combination Therapies
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
VERU | $1.42 22.41% 18.31% 7M
|
Health Technology
|
| O: -1.01%
H: 14.29%
C: 13.27%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
report reach market
China's First NDA for a KRAS G12C Inhibitor: Innovent Announces the National Medical Products Administration of China Has Accepted and Granted Priority Review Designation to the New Drug Application for IBI351
Published: 2023-11-24 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.69%
H: 1.66%
C: 1.66%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.46%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.34%
H: 0.37%
C: 0.3%
ibi351 drug granted review designation medical application china
Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.94%
H: 2.55%
C: 2.55%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.52%
H: 0.04%
C: 0.04%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.87%
H: 0.73%
C: 0.28%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.16%
H: 0.7%
C: 0.57%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -4.06%
H: 1.9%
C: 0.96%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
expected reach global dna medical technology market
Technological Advancements and Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -18.18%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -3.68%
H: 0.0%
C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.17%
C: -2.45%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.23%
H: 0.08%
C: -1.92%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: -0.59%
H: 0.15%
C: -1.79%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -15.73%
H: 0.0%
C: 0.0%
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: 3.73%
H: 1.8%
C: -4.19%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.45%
H: 0.12%
C: -2.28%
propel disease research therapeutics growth market
Pharmaceutical Suppositories Market to Reach $2.8 Billion, Globally, by 2032 at 5.7% CAGR: Allied Market Research
Published: 2023-10-24 (Crawled : 01:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.45%
H: 2.46%
C: 1.67%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.17%
H: 1.02%
C: 0.4%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: 0.0%
reach research market
Global Alport Syndrome Treatment Market Set to Surge, Projected to Reach USD 19.00 Million by 2032
Published: 2023-08-31 (Crawled : 01:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
reach treatment global set market
Empowering Healthcare: Global Vaccine Management System Market to Reach $441.17 million by 2028
Published: 2023-08-30 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: -2.26%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.25%
H: 0.47%
C: -1.08%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.54%
H: 0.27%
C: -0.59%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.46%
H: 0.17%
C: -0.86%
management vaccine reach global system market
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.